Merrimack Pharmaceuticals
MACK
#7637
Rank
A$0.33 B
Marketcap
$22.69
Share price
0.00%
Change (1 day)
19.30%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2023 (TTM): -$0.17

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.16. In 2022 the company made an earnings per share (EPS) of -$0.16 an increase over its 2021 EPS that were of -$0.27.

EPS history for Merrimack Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.170.38%
2022-$0.16-38.89%
2021-$0.27-25%
2020-$0.36-81.54%
2019-$1.95-56.95%
2018-$4.53-108.5%
2017$53.26-390.35%
2016-$18.34-7.35%
2015-$19.8065%
2014-$12.00-39.39%
2013-$19.80-54.01%
2012-$43.05-53.71%
2011-$93.0040.37%
2010-$66.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$4.77-2,991.14%๐Ÿ‡ซ๐Ÿ‡ท France
-$1.26 663.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.51 209.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.83 1,618.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.46 5,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA